Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 4
2014 8
2015 13
2016 21
2017 24
2018 15
2019 19
2020 11
Text availability
Article attribute
Article type
Publication date

Search Results

101 results
Results by year
Filters applied: . Clear all
Page 1
Nanoparticle-drug conjugates treating bacterial infections.
Jelinkova P, Mazumdar A, Sur VP, Kociova S, Dolezelikova K, Jimenez AMJ, Koudelkova Z, Mishra PK, Smerkova K, Heger Z, Vaculovicova M, Moulick A, Adam V. Jelinkova P, et al. Among authors: heger z. J Control Release. 2019 Aug 10;307:166-185. doi: 10.1016/j.jconrel.2019.06.013. Epub 2019 Jun 19. J Control Release. 2019. PMID: 31226356 Review.
Influence of Long-Distance Bicycle Riding on Serum/Urinary Biomarkers of Prostate Cancer.
Heger Z, Gumulec J, Ondrak A, Skoda J, Zitka Z, Cernei N, Masarik M, Zitka O, Adam V. Heger Z, et al. Int J Mol Sci. 2016 Mar 17;17(3):377. doi: 10.3390/ijms17030377. Int J Mol Sci. 2016. PMID: 26999116 Free PMC article.
Metallothioneins in Prion- and Amyloid-Related Diseases.
Adam P, Křížková S, Heger Z, Babula P, Pekařík V, Vaculovičoá M, Gomes CM, Kizek R, Adam V. Adam P, et al. Among authors: heger z. J Alzheimers Dis. 2016;51(3):637-56. doi: 10.3233/JAD-150984. J Alzheimers Dis. 2016. PMID: 26923022 Review.
Identification of Human Enzymes Oxidizing the Anti-Thyroid-Cancer Drug Vandetanib and Explanation of the High Efficiency of Cytochrome P450 3A4 in its Oxidation.
Indra R, Pompach P, Martínek V, Takácsová P, Vavrová K, Heger Z, Adam V, Eckschlager T, Kopečková K, Arlt VM, Stiborová M. Indra R, et al. Among authors: heger z. Int J Mol Sci. 2019 Jul 10;20(14):3392. doi: 10.3390/ijms20143392. Int J Mol Sci. 2019. PMID: 31295928 Free PMC article.
Cytochrome P450 and flavin-containing monooxygenase enzymes are responsible for differential oxidation of the anti-thyroid-cancer drug vandetanib by human and rat hepatic microsomal systems.
Indra R, Pompach P, Vavrová K, Jáklová K, Heger Z, Adam V, Eckschlager T, Kopečková K, Arlt VM, Stiborová M. Indra R, et al. Among authors: heger z. Environ Toxicol Pharmacol. 2020 Feb;74:103310. doi: 10.1016/j.etap.2019.103310. Epub 2019 Dec 3. Environ Toxicol Pharmacol. 2020. PMID: 31837525
Tyrosine kinase inhibitors vandetanib, lenvatinib and cabozantinib modulate oxidation of an anticancer agent ellipticine catalyzed by cytochromes P450 in vitro.
Kolarik M, Indra R, Adam V, Heger Z, Kopeckova K, Arlt VM, Stiborova M. Kolarik M, et al. Among authors: heger z. Neuro Endocrinol Lett. 2019 Feb;39(7):515-524. Neuro Endocrinol Lett. 2019. PMID: 30860683
Apoferritin applications in nanomedicine.
Heger Z, Skalickova S, Zitka O, Adam V, Kizek R. Heger Z, et al. Nanomedicine (Lond). 2014 Jul;9(14):2233-45. doi: 10.2217/nnm.14.119. Nanomedicine (Lond). 2014. PMID: 25405799 Review.
Nanotechnologies in protein microarrays.
Krizkova S, Heger Z, Zalewska M, Moulick A, Adam V, Kizek R. Krizkova S, et al. Among authors: heger z. Nanomedicine (Lond). 2015;10(17):2743-55. doi: 10.2217/nnm.15.81. Epub 2015 May 21. Nanomedicine (Lond). 2015. PMID: 26039143 Free article. Review.
Transport phenomena of nanoparticles in plants and animals/humans.
Anjum NA, Rodrigo MAM, Moulick A, Heger Z, Kopel P, Zítka O, Adam V, Lukatkin AS, Duarte AC, Pereira E, Kizek R. Anjum NA, et al. Among authors: heger z. Environ Res. 2016 Nov;151:233-243. doi: 10.1016/j.envres.2016.07.018. Epub 2016 Aug 6. Environ Res. 2016. PMID: 27504871 Review.
Transcriptomic Landscape of Cisplatin-Resistant Neuroblastoma Cells.
Rodrigo MAM, Buchtelova H, Jimenez AMJ, Adam P, Babula P, Heger Z, Adam V. Rodrigo MAM, et al. Among authors: heger z. Cells. 2019 Mar 12;8(3):235. doi: 10.3390/cells8030235. Cells. 2019. PMID: 30871063 Free PMC article.
101 results
Jump to page
Feedback